Literature DB >> 10797232

Mutational analysis of the structure and function of opioid receptors.

P Y Law1, Y H Wong, H H Loh.   

Abstract

The cloning of the opioid receptors allows the investigation of receptor domains involved in the peptidic and nonpeptidic ligand interaction and activation of the opioid receptors. Receptor chimera studies and mutational analysis of the primary sequences of the opioid receptors have provided insights into the structural domains required for the ligand recognition and receptor activation. In the current review, we examine the current reports on the possible involvement of extracellular domains and transmembrane domains in the high-affinity binding of peptidic and nonpeptidic ligands to the opioid receptor. The structural requirement for the receptors' selectivity toward different ligands is discussed. The receptor domains involved in the activation and subsequent cellular regulation of the receptors' activities as determined by mutational analysis will also be discussed. Finally, the validity of the conclusions based on single amino acid mutations is examined. Copyright 2000 John Wiley & Sons, Inc.

Mesh:

Substances:

Year:  1999        PMID: 10797232     DOI: 10.1002/(SICI)1097-0282(1999)51:6<440::AID-BIP6>3.0.CO;2-T

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  13 in total

Review 1.  Genetic variations in human G protein-coupled receptors: implications for drug therapy.

Authors:  W Sadee; E Hoeg; J Lucas; D Wang
Journal:  AAPS PharmSci       Date:  2001

2.  Docking studies suggest ligand-specific delta-opioid receptor conformations.

Authors:  Vuk Micovic; Milovan D Ivanovic; Ljiljana Dosen-Micovic
Journal:  J Mol Model       Date:  2008-12-04       Impact factor: 1.810

Review 3.  Recent advances on the δ opioid receptor: from trafficking to function.

Authors:  Louis Gendron; Nitish Mittal; Hélène Beaudry; Wendy Walwyn
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

4.  The adaptor Grb7 links netrin-1 signaling to regulation of mRNA translation.

Authors:  Nien-Pei Tsai; Jing Bi; Li-Na Wei
Journal:  EMBO J       Date:  2007-02-22       Impact factor: 11.598

5.  The role of the hydrophilic Asn230 residue of the mu-opioid receptor in the potency of various opioid agonists.

Authors:  J Pil; J Tytgat
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

6.  Discovery of dermorphin-based affinity labels with subnanomolar affinity for mu opioid receptors.

Authors:  Bhaswati Sinha; Zhengyu Cao; Thomas F Murray; Jane V Aldrich
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

7.  Chronic morphine treatment up-regulates mu opioid receptor binding in cells lacking filamin A.

Authors:  Irma Onoprishvili; Eric J Simon
Journal:  Brain Res       Date:  2007-08-16       Impact factor: 3.252

8.  Changes in opioid receptor proteins during mitochondrial impairment in differentiated SK-N-SH cells.

Authors:  Atul Raut; Vidhya R Rao; Anna Ratka
Journal:  Neurosci Lett       Date:  2007-06-17       Impact factor: 3.046

9.  Src phosphorylation of micro-receptor is responsible for the receptor switching from an inhibitory to a stimulatory signal.

Authors:  Lei Zhang; Hui Zhao; Yu Qiu; Horace H Loh; Ping-Yee Law
Journal:  J Biol Chem       Date:  2008-11-24       Impact factor: 5.157

10.  Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists.

Authors:  Guo Li; Lindsey C Aschenbach; Jianyang Chen; Michael P Cassidy; David L Stevens; Bichoy H Gabra; Dana E Selley; William L Dewey; Richard B Westkaemper; Yan Zhang
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.